Spirulina did not ameliorate idiopathic chronic fatigue in four N-of-1 randomized controlled trials

Phytotherapy Research

Volumn 21, Issue 6, 2007, Pages 570-573

  Baicus, Cristian ^a,b   Baicus, Anda ^c  

^a Department of Internal Medicine   (Romania)

^b Spitalul Colentina   (Romania)

^c CANTACUZINO INSTITUTE   (Romania)

Author keywords

Double blind; N of 1 trial; Randomization; Single case research; Spirulina

Indexed keywords

PLACEBO; PLANT EXTRACT; SPIRULINA PLATENSIS EXTRACT; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FATIGUE; HUMAN; PHYSICIAN; RANDOMIZED CONTROLLED TRIAL; SPIRULINA; SPIRULINA PLATENSIS;

ADULT; BIOLOGICAL FACTORS; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FATIGUE; HUMANS; SPIRULINA; TREATMENT OUTCOME;

ALGAE; SPIRULINA; SPIRULINA PLATENSIS;

EID: 34250328664     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2114     Document Type: Article

References (13)

1. Baicus C, Tanasescu C. 2002. In chronic viral hepatitis, the treatment with spiruline for one month has no effect on the aminotransferases. Rom J Intern Med 40: 89-94.
2. Branger B, Cadudal JL, Delobel M et al. 2003. Spiruline as a food supplement in case of infant malnutrition in Burkina-Faso [Article in French]. Arch Pediatr 10: 424-431.
3. Cifferi O. 1983. Spirulina, the edible microorganism. Microbiol Rev 47: 551-578.
4. Guyatt G, Haynes B, Jaeschke R et al. 2002a. Introduction: the philosophy of evidence-based medicine. In User's Guides to the Medical Literature. A Manual for Evidence-based Medicine, Guyatt G, Rennie D (eds). American Medical Association Press: Chicago; 2-12.
5. Guyatt G, Jaeschke R, McGinn T. 2002b. Therapy and validity. N of 1 randomized controlled trials. In User's Guides to the Medical Literature. A Manual for Evidence-based Medicine, Guyatt G, Rennie D (eds). American Medical Association Press: Chicago; 275-290.
6. Guyatt GH, Sackett D, Taylor DW et al. 1986. Determining optimal therapy - randomized trials in individual patients. N Engl J Med 314: 889-892.
7. Ionov VA, Basova MM. 2003. Use of blue-green micro-seaweed Spirulina platensis for the correction of lipid and hemostatic disturbances in patients with ischemic heart disease. Vopr Pitan 72: 28-31.
8. Mani UV, Desai S, Iyer U. 2000. Studies on the long-term effect of spirulina supplementation on serum lipid profile and glycated proteins in NIDDM patients. J Nutraceut 2: 25-32.
9. Mathew B, Sankaranarayanan R, Nair PP et al. 1995. Evaluation of chemoprevention of oral cancer with Spirulina fusiformis. Nutr Cancer 24: 197-202.
10. Okkes IM, Oskam SK, Lamberts H. 2002. The probability of specific diagnoses for patients presenting with common symptoms to Dutch family physicians. J Fam Pract 51: 31-36.
11. Portney LG, Watkins M. 1993. Single-case experimental designs. In Foundations of Clinical Research. Applications to Practice. Appleton and Lange: Norwalk; 191-232.
12. Sackett D, Haynes B, Guyatt G, Tugwell P. 1991. Clinical Epidemiology. A Basic Science for Clinical Medicine, 2nd edn. Little, Brown: Boston; 223-238.
13. Samuels R, Mani UV, Iyer UM, Nayak US. 2002. Hypocholesterolemic effect of spirulina in patients with hyperlipidemic nephrotic syndrome. J Med Food 5: 91-96.